Harpoon Therapeutics

board

Harpoon Therapeutics is a company.

select Filter
All
Business
Culture
Environment
Health
Politics
Research

Key facts

Latest news (see all)

Merck to Buy Harpoon Therapeutics for $680 Million

Read: The Wall Street Journal

2024-01-08

Metrics

Business

assets 155.5M $
Debt 11.8M $
free cash flow -73,517,600.00
market cap 54,690,200.00

Visualizations

Datasets

Source

This dashboard is based on data from: Twitter, YAHOO-FIN, YFINANCE

Updated: 2 days ago

License

This content can be used under the CC BY 4.0 license

Going further

We would recommend you have a look at connected dashboards:
dark About